[HTML][HTML] Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse
…, YZ Abdulhamid, B Rambaldi, Y Arihara… - The Journal of …, 2022 - Am Soc Clin Investig
Background Responses to conventional donor lymphocyte infusion for postallogeneic
hematopoietic cell transplantation (HCT) relapse are typically poor. Natural killer (NK) cell–based …
hematopoietic cell transplantation (HCT) relapse are typically poor. Natural killer (NK) cell–based …
Impaired T-and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide
…, C Reynolds, S Chamling Rai, Y Arihara… - Blood …, 2021 - ashpublications.org
Administration of posttransplant cyclophosphamide (PTCy) has significantly expanded the
number of patients undergoing HLA-haploidentical hematopoietic cell transplantation (haplo-…
number of patients undergoing HLA-haploidentical hematopoietic cell transplantation (haplo-…
Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings
Two articles in this week’s issue focus on the use of ipilimumab and decitabine for patients
with myelodysplasia (MDS) and acute myeloid leukemia (AML) before and after …
with myelodysplasia (MDS) and acute myeloid leukemia (AML) before and after …
[HTML][HTML] RNAi-mediated gene silencing of ST6GalNAc I suppresses the metastatic potential in gastric cancer cells
…, M Ono, T Osuga, Y Okagawa, N Uemura, Y Arihara… - Gastric cancer, 2016 - Springer
Background ST6GalNAc I is a sialyltransferase controlling the expression of sialyl-Tn antigen
(STn), which is overexpressed in several epithelial cancers, including gastric cancer, and …
(STn), which is overexpressed in several epithelial cancers, including gastric cancer, and …
[HTML][HTML] The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma
…, K Takada, T Sato, Y Kawano, K Murase, Y Arihara… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Deregulated iron metabolism underlies the pathogenesis of many human cancers. Recently,
low expression of ferroportin, which is the only identified non-heme iron exporter, has been …
low expression of ferroportin, which is the only identified non-heme iron exporter, has been …
Relationship between increased fucosylation and metastatic potential in colorectal cancer
…, Y Okagawa, N Uemura, Y Arihara… - Journal of the …, 2016 - academic.oup.com
Background: Fucose is utilized for the modification of different molecules involved in blood
group determination, immunological reactions, and signal transduction pathways. We have …
group determination, immunological reactions, and signal transduction pathways. We have …
[HTML][HTML] Phase I study of PHE885, a fully human BCMA-directed CAR-T cell therapy for relapsed/refractory multiple myeloma manufactured in< 2 days using the T …
…, DH Rodriguez, H Daley, KL Shaw, Y Arihara… - Blood, 2021 - Elsevier
Background: Chimeric antigen receptor (CAR)-T cells are highly effective in patients (pts)
with multiple myeloma (MM), but duration of response can be limited, and pts with rapidly …
with multiple myeloma (MM), but duration of response can be limited, and pts with rapidly …
[HTML][HTML] Effect of comprehensive cancer genomic profiling on therapeutic strategies and clinical outcomes in patients with advanced biliary tract cancer: a prospective …
…, J Kikuchi, M Yoshida, A Murota, Y Arihara… - Frontiers in …, 2022 - frontiersin.org
Characterization of the genomic landscape of biliary tract cancer (BTC) may lead to applying
genotype-matched therapy for patients with this disease. Evidence that comprehensive …
genotype-matched therapy for patients with this disease. Evidence that comprehensive …
Six-transmembrane epithelial antigen of the prostate 1 protects against increased oxidative stress via a nuclear erythroid 2-related factor pathway in colorectal cancer
H Nakamura, K Takada, Y Arihara, N Hayasaka… - Cancer Gene …, 2019 - nature.com
The over-expression of six-transmembrane epithelial antigen of the prostate 1 (STEAP1)
underlies the pathogenesis of a large subset of human cancers. Expressed on the cancer cell …
underlies the pathogenesis of a large subset of human cancers. Expressed on the cancer cell …
[HTML][HTML] Combination of eribulin plus AKT inhibitor evokes synergistic cytotoxicity in soft tissue sarcoma cells
N Hayasaka, K Takada, H Nakamura, Y Arihara… - Scientific Reports, 2019 - nature.com
An activated AKT pathway underlies the pathogenesis of soft tissue sarcoma (STS), with
over-expressed phosphorylated AKT (p-AKT) correlating with a poor prognosis in a subset of …
over-expressed phosphorylated AKT (p-AKT) correlating with a poor prognosis in a subset of …